Acinetobacter baumannii complex: Difference between revisions
From IDWiki
Acinetobacter baumannii complex
No edit summary |
m (Text replacement - "[[Cellular shape::" to "[[Shape::") |
||
| Line 4: | Line 4: | ||
*Contains ''Acinetobacter baumannii'', ''[[Acinetobacter nosocomialis]]'', and ''[[Acinetobacter pittii]]'' |
*Contains ''Acinetobacter baumannii'', ''[[Acinetobacter nosocomialis]]'', and ''[[Acinetobacter pittii]]'' |
||
| − | *Non-motile, non-fermenting [[Stain::Gram-negative]] [[ |
+ | *Non-motile, non-fermenting [[Stain::Gram-negative]] [[Shape::bacillus]] |
== Management == |
== Management == |
||
Revision as of 09:22, 8 October 2020
Background
Microbiology
- Contains Acinetobacter baumannii, Acinetobacter nosocomialis, and Acinetobacter pittii
- Non-motile, non-fermenting Gram-negative bacillus
Management
- Choice of antibiotic depends on susceptibility testing
- Possible options include:
- Cefepime, ceftriaxone, and cefotaxime
- Cefiderocol
- Carbapenems
- Tigecycline
- Colistin and polymyxin B (though Acinetobacter junii has inherent resistance)
- Aminoglycosides may not penetrate well into lungs and brain, so are usually avoided
- Bacteriophages are promising
